SPES IMMUNOTHERAPEUTICS S.L.
A Healthtech startup included in the Barcelona & Catalonia Startup Hub
SPES IMMUNO
Spes Immunotherapeutics is a biotechnology company developing personalized therapeutic vaccines intended to prevent leukemia relapse in pediatric patients. Its research focuses on precision immunotherapy approaches designed to stimulate targeted immune responses against leukemia-associated molecular abnormalities. The company aims to develop new therapeutic strategies for childhood leukemia, addressing disease recurrence through personalized cancer vaccine development.
Industries & Technologies
Industries:
Healthtech
Technologies:
Personalized medicine
Other fields:
-
Financial data
Funding stage:
Founded: 2025
Employees:
Other information
Business model:
Development & Manufacturing,
Other types of licence
Target:
Business
Spinoff participants:
None / Not a spinoff
Other startups near startup SPES IMMUNO
similar companies
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.